Skip to main content
. 2022 Jul 7;148(9):830–837. doi: 10.1001/jamaoto.2022.1573

Table 2. Self-reported Assessment of Smell and Changes in Ability to Smell at Baseline, 3 Weeks, and 6 Weeksa.

Assessment Categories Theophylline arm, No. (%) (n = 26) Placebo arm, No. (%) (n = 25)
Baseline 3 Weeks 6 Weeks Baseline 3 Weeks 6 Weeks
Change in ability to smell from baseline (CGI-I) Much better NA 0 0 NA 0 1 (4)
Somewhat better NA 0 4 (18) NA 2 (9) 4 (17)
Slightly better NA 8 (35) 9 (41) NA 7 (30) 5 (22)
Neither better nor worse NA 15 (58) 5 (23) NA 13 (57) 12 (52)
Slightly worse NA 0 1 (4) NA 1 (4) 0
Somewhat worse NA 0 1 (4) NA 0 0
Much worse NA 0 2 (9) NA 0 1 (4)
Overall ability to smell (CGI-S) Very good 0 0 0 0 0 1 (4)
Good 0 1 (4) 1 (4) 1 (4) 1 (4) 2 (9)
Fair 1 (4) 3 (13) 6 (27) 3 (12) 6 (26) 6 (26)
Poor 17 (71) 16 (70) 10 (46) 16 (64) 12 (52) 11 (48)
Absent 6 (25) 3 (13) 5 (23) 5 (20) 4 (18) 3 (13)

Abbreviations: CGI-I, Clinical Global Impression-Improvement; CGI-S, Clinical Global Impression-Severity; NA, not applicable.

a

Four participants in the theophylline arm and 2 participants in the placebo arm were either lost to follow-up, discontinued the study for inability to tolerate nasal irrigations, or were withdrawn for medical reasons.